Is IRON Overvalued?

IRON is now in the Fair zone, suggesting that IRON current forward PE ratio of -10.09 is considered Fair compare with the five-year average of -11.12.
P/E
EV/EBITDA
P/S
P/B
bubble
P/E

IRON Competitors Valuation Multiple

P/E
EV/EBITDA
P/S

P/E Multiple

Earnings Growth
Market Cap
stocks logo
IRON.O
Disc Medicine Inc
loss
Average P/E: 38.72
-1.82%
1.63B
stocks logo
ARWR.O
Arrowhead Pharmaceuticals Inc
loss
1.68B
stocks logo
JANX.O
Janux Therapeutics Inc
loss
-41.26%
1.58B
stocks logo
VERA.O
Vera Therapeutics Inc
loss
-23.98%
1.40B
stocks logo
DVAX.O
Dynavax Technologies Corp
38.72
3049.70%
1.58B
stocks logo
KYMR.O
Kymera Therapeutics Inc
loss
-259.40%
1.64B

IRON Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

IRON FAQs

Is IRON currently overvalued based on its P/E ratio?

According to the provided data, IRON's 5-year historical average forward P/E ratio is -11.12. IRON forward P/E ratio is -10.09, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for IRON?

What are the key indicators to watch for IRON's financial performance?

IRON PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average PE
-11.12
Current PE
-10.09
Overvalued PE
-7.79
Undervalued PE
-14.44

IRON EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average EV
-6.75
Current EV
-6.33
Overvalued EV
-4.81
Undervalued EV
-8.69

IRON P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Strongly Undervalued
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is IRON undervalued?Is IRON overvalued compared to its competitors?